Contact Us

Saadia Pharmaceuticals’ Team Publishes Abilify® (Otsuka/Lundbeck Pharmaceuticals) to Vraylar® (AbbVie Pharmaceuticals) Cross-Over Study In General Hospital Psychiatry

Share an article:

Other News

  • In The News

Saadia Pharmaceuticals’ Team Gets Published in Nature

Learn More
  • In The News

Saadia Pharmaceuticals’ Team Featured in Yale Psychiatry News

Learn More
  • In The News

Saadia Pharmaceuticals’ Team Delivers NEI Podcast Discussing Vraylar®(Abbvie).

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Publishes Spravato® (Janssen) Review Article in Biomarkers in Neuropsychiatry

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Gives Presentation to 900K Prescribers on Vumedi

Learn More
  • Posters & Publications

Saadia Pharmaceuticals’ Team Publishes Rebutal on Vraylar® (AbbVie Pharmaceuticals) study on use for Bipolar I Disorder Maintenance

Learn More

© 2024 Saadia Pharmaceuticals, Inc. All Rights Reserved.

© 2024 Saadia Pharmaceuticals, Inc.